Search for: "In re Goldman Sachs Group, Inc. Securities Litigation" Results 21 - 37 of 37
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2016, 4:59 pm by Kevin LaCroix
  That theory has been a primary enabler of class action securities litigation under Section 10(b) of the Securities Exchange Act of 1934. [read post]
24 Mar 2016, 5:32 am
  See In re Biomet M2a Magnum Hip Implant Products Liability Litigation, 2013 WL 6405156, at *2 (N.D. [read post]
29 Feb 2016, 4:43 pm by Kevin LaCroix
In the following memorandum from the Haynes and Boone law firm, attorneys from the firm’s Securities and Shareholder Litigation group take a look at the important securities litigation developments during 2015. [read post]
1 Aug 2012, 5:51 am by Mandelman
Gibbs, President of the Municipal Securities Group, Jefferies & Company, Inc. [read post]
17 Jan 2012, 5:50 pm by Robert Milligan
 At least one Georgia court has interpreted the new Act as providing courts discretion to re-write restrictive covenants to make them enforceable, rather than merely providing the authority to remove overbroad covenants. [read post]
15 Sep 2011, 8:44 am by William McGrath
Today, the Federal Securities Law Blog takes a look back at the last 30 days in the world of securities-related litigation in a regular feature which appears on approximately the 15th of each month. [read post]
25 Aug 2010, 9:16 am by Kara OBrien
  Unlike in Maric, in this case no free cash flow estimates were actually provided to Goldman Sachs. [read post]
4 May 2010, 11:56 am by Christine Hurt
Delaware Derivative Suit:  In re The Goldman Sachs Group, Inc. [read post]
Of particular note, in December, the Securities and Exchange Commission (”SEC”) adopted new proxy disclosure rules that likely will be a focal point for public company directors, as the new rules relate to disclosures regarding the composition and operation of boards of directors. [1] This memorandum is an update of our client alert covering considerations for public company directors in the current environment issued on October 15, 2009. 1. [read post]
19 May 2009, 2:51 am
" All three legal departments that were selected this year (the winner, runner-up, and finalist) remained firm in their commitment to value, innovation, and diversity even in the face of adversity.Winner: The Hartford Financial Services Group Inc.Runner-Up: International Business Machines CorporationFinalist: Exelon CorporationSee below what made each of these legal departments stand out from the crowd: The Hartford Financial Services Group 2008 Revenue/Net… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to… [read post]